Combined treatment with cisplatin and the Dyrk1B inhibitor AZ191 effectively inhibited tumor growth in xenograft tumor assays in BALB/c nude mice injected with Hep3B or PLC8024 hepatocellular carcinoma cell lines [75]. Here, DYRK1B is linked to neoplasm.